chrX-154361480-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001110556.2(FLNA):​c.3035C>T​(p.Ser1012Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00735 in 1,209,121 control chromosomes in the GnomAD database, including 391 homozygotes. There are 2,367 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S1012A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.038 ( 177 hom., 1091 hem., cov: 22)
Exomes 𝑓: 0.0043 ( 214 hom. 1276 hem. )

Consequence

FLNA
NM_001110556.2 missense

Scores

3
5
7

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:16

Conservation

PhyloP100: 2.92

Publications

10 publications found
Variant links:
Genes affected
FLNA (HGNC:3754): (filamin A) The protein encoded by this gene is an actin-binding protein that crosslinks actin filaments and links actin filaments to membrane glycoproteins. The encoded protein is involved in remodeling the cytoskeleton to effect changes in cell shape and migration. This protein interacts with integrins, transmembrane receptor complexes, and second messengers. Defects in this gene are a cause of several syndromes, including periventricular nodular heterotopias (PVNH1, PVNH4), otopalatodigital syndromes (OPD1, OPD2), frontometaphyseal dysplasia (FMD), Melnick-Needles syndrome (MNS), and X-linked congenital idiopathic intestinal pseudoobstruction (CIIPX). Two transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2009]
FLNA Gene-Disease associations (from GenCC):
  • periventricular nodular heterotopia
    Inheritance: AD, XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • frontometaphyseal dysplasia 1
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • genetic developmental and epileptic encephalopathy
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • heterotopia, periventricular, X-linked dominant
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Illumina
  • intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linked
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Melnick-Needles syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • otopalatodigital syndrome type 2
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • terminal osseous dysplasia-pigmentary defects syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • cardiac valvular dysplasia, X-linked
    Inheritance: XL Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • frontometaphyseal dysplasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital short bowel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • otopalatodigital syndrome type 1
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked Ehlers-Danlos syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: XL Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003318429).
BP6
Variant X-154361480-G-A is Benign according to our data. Variant chrX-154361480-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 93753.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.126 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001110556.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FLNA
NM_001110556.2
MANE Select
c.3035C>Tp.Ser1012Leu
missense
Exon 21 of 48NP_001104026.1
FLNA
NM_001456.4
c.3035C>Tp.Ser1012Leu
missense
Exon 21 of 47NP_001447.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FLNA
ENST00000369850.10
TSL:1 MANE Select
c.3035C>Tp.Ser1012Leu
missense
Exon 21 of 48ENSP00000358866.3
FLNA
ENST00000360319.9
TSL:1
c.3035C>Tp.Ser1012Leu
missense
Exon 20 of 46ENSP00000353467.4
FLNA
ENST00000369856.8
TSL:1
c.2954C>Tp.Ser985Leu
missense
Exon 20 of 47ENSP00000358872.4

Frequencies

GnomAD3 genomes
AF:
0.0379
AC:
4216
AN:
111385
Hom.:
177
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.129
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000279
Gnomad SAS
AF:
0.00111
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00420
Gnomad NFE
AF:
0.000472
Gnomad OTH
AF:
0.0307
GnomAD2 exomes
AF:
0.0111
AC:
2009
AN:
181414
AF XY:
0.00733
show subpopulations
Gnomad AFR exome
AF:
0.140
Gnomad AMR exome
AF:
0.00785
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000357
Gnomad OTH exome
AF:
0.00628
GnomAD4 exome
AF:
0.00425
AC:
4668
AN:
1097681
Hom.:
214
Cov.:
33
AF XY:
0.00351
AC XY:
1276
AN XY:
363213
show subpopulations
African (AFR)
AF:
0.138
AC:
3648
AN:
26396
American (AMR)
AF:
0.00915
AC:
322
AN:
35206
Ashkenazi Jewish (ASJ)
AF:
0.0000516
AC:
1
AN:
19385
East Asian (EAS)
AF:
0.0000662
AC:
2
AN:
30206
South Asian (SAS)
AF:
0.000351
AC:
19
AN:
54142
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40188
Middle Eastern (MID)
AF:
0.00919
AC:
38
AN:
4136
European-Non Finnish (NFE)
AF:
0.000219
AC:
184
AN:
841943
Other (OTH)
AF:
0.00985
AC:
454
AN:
46079
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
216
432
648
864
1080
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
114
228
342
456
570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0379
AC:
4224
AN:
111440
Hom.:
177
Cov.:
22
AF XY:
0.0324
AC XY:
1091
AN XY:
33660
show subpopulations
African (AFR)
AF:
0.129
AC:
3943
AN:
30553
American (AMR)
AF:
0.0195
AC:
206
AN:
10549
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2647
East Asian (EAS)
AF:
0.000280
AC:
1
AN:
3572
South Asian (SAS)
AF:
0.000745
AC:
2
AN:
2683
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6068
Middle Eastern (MID)
AF:
0.00461
AC:
1
AN:
217
European-Non Finnish (NFE)
AF:
0.000472
AC:
25
AN:
52948
Other (OTH)
AF:
0.0303
AC:
46
AN:
1518
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
140
279
419
558
698
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0240
Hom.:
526
Bravo
AF:
0.0449
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.136
AC:
497
ESP6500EA
AF:
0.000456
AC:
3
ExAC
AF:
0.0118
AC:
1433
EpiCase
AF:
0.000491
EpiControl
AF:
0.000771

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:16
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:8
Jun 05, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed.

Jul 10, 2013
Claritas Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Mar 21, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Jul 21, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BA1;BP6

Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not provided Benign:4
Feb 11, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Oct 28, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Familial thoracic aortic aneurysm and aortic dissection Benign:1
Jul 20, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Melnick-Needles syndrome;C0265293:Frontometaphyseal dysplasia;C1844696:Oto-palato-digital syndrome, type II;C1848213:Heterotopia, periventricular, X-linked dominant Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Melnick-Needles syndrome;C0262436:Cardiac valvular dysplasia, X-linked;C0265251:Oto-palato-digital syndrome, type I;C1844696:Oto-palato-digital syndrome, type II;C1845902:FG syndrome 2;C1846129:Terminal osseous dysplasia-pigmentary defects syndrome;C1848213:Heterotopia, periventricular, X-linked dominant;C2746068:Intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linked;C4281559:Frontometaphyseal dysplasia 1 Benign:1
Dec 01, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Connective tissue disorder Benign:1
Nov 01, 2016
Center for Human Genetics, Inc, Center for Human Genetics, Inc
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
20
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.86
D
FATHMM_MKL
Benign
0.66
D
LIST_S2
Uncertain
0.91
D
MetaRNN
Benign
0.0033
T
MetaSVM
Benign
-0.71
T
MutationAssessor
Pathogenic
2.9
M
PhyloP100
2.9
PrimateAI
Benign
0.43
T
PROVEAN
Pathogenic
-4.6
D
REVEL
Uncertain
0.40
Sift
Uncertain
0.011
D
Sift4G
Uncertain
0.0020
D
Polyphen
0.95
P
Vest4
0.21
MPC
0.61
ClinPred
0.066
T
GERP RS
4.7
Varity_R
0.62
gMVP
0.52
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17091204; hg19: chrX-153589848; COSMIC: COSV61054178; COSMIC: COSV61054178; API